FK 506 and rapamycin in combination are not antagonistic but produce extended small bowel graft survival in the mouse.
Chen
H
H
Laboratory of Experimental Surgery, Research Center, Notre-Dame Hospital, University of Montreal, Quebec, Canada.
Qi
S
S
Xu
D
D
Vu
D M
DM
Fitzsimmons
W E
WE
Bekersky
I
I
Peets
J
J
Sehgal
S N
SN
Daloze
P
P
D000208:Acute Disease; D000818:Animals; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007421:Intestine, Small / Q000637:transplantation*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D011090:Polyenes / Q000627:therapeutic use*; D020123:Sirolimus; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous / Q000276:immunology*
D007166:Immunosuppressive Agents; D011090:Polyenes; D020123:Sirolimus; D016559:Tacrolimus